Metraipolis › archive › dc_9f8a61972182

Age-stratified adverse-event reporting signals of seven ALK/ROS1 tyrosine kinase inhibitors in FAERS: a disproportionality and time to onset study — Europe PMC PMID:42769117

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42769117
DOI
10.3389/fphar.2026.1891628
License (as archived)
solo-consultazione
Archived
2026-10-08T14:17:48.483Z
SHA-256 of the archived text
5f03b3ef1ca72c6452b438b10492afbc9345460bf9a3c9f75f2adb433f5a8dd2
Stable URL of this page
https://metraipolis.com/documento/dc_9f8a61972182

How to cite

Age-stratified adverse-event reporting signals of seven ALK/ROS1 tyrosine kinase inhibitors in FAERS: a disproportionality and time to onset study — Europe PMC PMID:42769117 — Europe PMC (en), https://europepmc.org/article/MED/42769117 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9f8a61972182 (Metraipolis archive dc_9f8a61972182, sha256 5f03b3ef1ca72c6452b438b10492afbc9345460bf9a3c9f75f2adb433f5a8dd2)
BibTeX
@misc{dc9f8a61972182,
  title = {Age-stratified adverse-event reporting signals of seven ALK/ROS1 tyrosine kinase inhibitors in FAERS: a disproportionality and time to onset study — Europe PMC PMID:42769117},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42769117},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9f8a61972182; sha256 5f03b3ef1ca72c6452b438b10492afbc9345460bf9a3c9f75f2adb433f5a8dd2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42769117. Agents can read the archived copy with the MCP tool read_document.